Smoking Cessation And Nicotine De-Addiction Market 2024-2028: Size and Health issues associated with smoking cessation products; growth driven by the Distribution Channel, Some of key Companies Positioned Strategically

The smoking cessation and nicotine de-addiction market size by Distribution Channel (Drug stores and retailers, Hospital pharmacies, and Online retail), Product (E-cigarette, NRT, and Drug therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 36983.3 million. The market is expected to grow at a CAGR of   15.84% between 2024 and 2028.

• The Smoking Cessation and Nicotine De-Addiction Market may experience hindrances due to increasing concerns regarding the potential health risks associated with long-term use of nicotine replacement therapies, such as nicotine gums, patches, lozenges, and e-cigarettes. These products, while effective in helping individuals quit smoking, can cause various health complications. For instance, nicotine gums can lead to hair loss, skin irritation, elevated blood pressure, irregular heartbeat, insulin resistance, gastrointestinal issues, and nausea. Moreover, continuous chewing of nicotine gums can result in dental problems, including teeth and jaw issues. Nicotine patches, on the other hand, can cause skin irritation, itching, dizziness, and headaches. Despite these challenges, the market continues to grow due to the significant unmet need for effective smoking cessation solutions.
• The Smoking Cessation and Nicotine De-Addiction Market represents a significant business opportunity due to the growing health consciousness and increasing awareness about the harmful effects of tobacco use. This market encompasses various products and services aimed at helping individuals quit smoking, including nicotine replacement therapies, pharmacological interventions, and behavioral therapies. Companies in this sector focus on developing innovative solutions to address the challenges of nicotine addiction and improve success rates for smokers seeking to quit.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Alchem International Pvt. Ltd.
• Alkalon AS
• Alvogen Iceland ehf
• Axcentria Pharmaceuticals
• British American Tobacco Plc
• Cambrex Corp.
• CHEMNOVATIC Sp. z o.o. Sp. k
• Cipla Inc.
• Dr Reddys Laboratories Ltd.
• Enorama Pharma AB
• Imperial Brands Plc
• Japan Tobacco Inc.
• Johnson and Johnson Services Inc.
• Lil Drug Store Products Inc.
• Perrigo Co. Plc
• Pfizer Inc.
• Philip Morris International Inc.
• Qnovia
• Tvape
• Walgreens Boots Alliance Inc.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/